Dreamit Ventures and MedCityNews teamed up to get a pulse on the current appetite for innovation at large health systems across the United States. The survey data tapped senior innovation leaders, 85% of whom came from health systems with over 1,000 beds.

Today, Infermedica (HT ‘18) announced a $10M Series A financing round for their AI-driven platform that helps insurance, telemedicine companies, and health systems increase efficiency through fast, digital symptom-checks. The platform has nearly 60 B2B partners across 30 countries, including Microsoft, Allianz, Global Excel, Sana Kliniken, and Médis, and has performed more than 6 million health checks globally. Read here.

Last week, EnsoData (Healthtech - Spring 2019) announced a $9 million Series A financing round led by Venture Investors and Zetta Venture Partners, with participation from Dreamit Ventures. Their platform transforms billions of waveform data points collected from sensors in medical devices and wearables into an easy-to-read report, so clinicians can make faster, more accurate diagnoses.

More than 15 Dreamit Healthtech companies have products that are helping to mitigate the spread of COVID-19. These companies are actively deploying COVID-19 solutions in hospitals and healthcare systems. Read on to explore solutions by use case.

NarrativeDX (Healthtech - Fall 2014) is the latest win for the Dreamit portfolio. Today, the company announced that it is being acquired by health care performance improvement pioneer Press Ganey.

Early-stage investors will probably ask you about your exit strategy. Don’t fall into the traps of thinking small or leaving the party too early. You’re building the right venture for the right reasons so use exit as an opportunity to let that shine.

Telehealth is having a moment right now. With global psyche engrossed in COVID-19 press, this could be telehealth's 'put-me-in-coach' moment. Read on to dive deeper.

Getting investors excited about your product is a critical part of raising capital. But founders are often so consumed with talking metrics, milestones achieved, or the capital they need that they sometimes forget to talk about their overarching vision for their startups. In this article, we provide some strategies for selling investors on your vision for your startup.

BrainCheck (Dreamit Healthtech Fall 2016) raised $8M in funding. The startup helps physicians assess and track the mental health of their patients.

In this #DreamitLive, Healthtech Managing Director Adam Dakin speaks with Graftworx founder and CEO David Kuraguntla about his startup’s path to commercialization.